- Home
- Products
BEVYXXA (Betrixaban)
BEVYXXA (Betrixaban)
- Medicine Name: Bevyxxa
- Generic Name: Betrixaban
- Dosage Form & Strength: Capsules – 40 mg and 80 mg
- Manufactured By: Portola Pharmaceuticals
- FDA Approved: Yes (Approval Date: 2017)
Bevyxxa (Betrixaban) is a factor Xa inhibitor indicated for the prophylaxis of venous thromboembolism (VTE) in adult patients hospitalized for acute medical illness who are at increased risk due to:
- Prolonged immobility
- Acute heart failure
- Respiratory disorders
- Stroke
- Infections, or
- Risk factors such as advanced age or a history of VTE
Bevyxxa helps reduce the risk of developing blood clots during and after hospitalization.
Recommended Usage
Bevyxxa is available in:
- 40 mg capsules – typically used for dose adjustment in renal impairment
- 80 mg capsules – standard daily maintenance dosage
Administer orally with food. Treatment duration and dosing should be guided by the prescribing physician based on patient risk profile.
- Bleeding Risk: Betrixaban can increase the risk of bleeding. Use cautiously in patients with bleeding disorders or those on concurrent anticoagulants or antiplatelet drugs.
- Spinal/Epidural Hematoma: Patients undergoing spinal procedures may be at increased risk of hematoma. Monitor closely.
- Renal Impairment: Dosage adjustment is required. Bevyxxa is not recommended for patients with severe renal dysfunction (CrCl < 15 mL/min).
- Drug Interactions: Bevyxxa should not be used concurrently with other strong P-gp inhibitors (e.g., ketoconazole).
- Liver Function: Not recommended in patients with significant hepatic impairment due to increased risk of bleeding.
To import Bevyxxa (Betrixaban) to India, the following documentation is required:
- Valid medical prescription from a licensed practitioner
- Patient’s diagnostic reports
- Government-issued identity proof
📍 Available In: Mumbai, Delhi, Kolkata, Chennai, Hyderabad, Bangalore, Ahmedabad, Pune, and other major cities.
📧 Email: info@globalraremeds.com
📞 Phone/WhatsApp: +91-99675 15602
Global Rare Meds guarantees:
- Authentic sourcing from USA, Canada, Europe, and Australia
- Rapid fulfillment from our Ambernath (Thane District) center
- Verified pharmacists and regulatory compliance
- Cold chain or temperature-controlled delivery as needed
- Global doorstep delivery
Q: What is the generic name of Bevyxxa?
A: Betrixaban.
Q: What is Bevyxxa used for?
A: Prevention of venous thromboembolism (VTE) in acutely ill hospitalized adults.
Q: How is Bevyxxa administered?
A: Orally, with food. Dosage and treatment duration as per physician’s prescription.
Q: Is Bevyxxa approved by the FDA?
A: Yes. Approved by the US FDA in 2017.
Q: What are the common side effects of Bevyxxa?
A: Bleeding, anemia, nausea, constipation, and urinary tract infections.
Q: What are the storage conditions for Bevyxxa?
A: Store between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C and 30°C (59°F to 86°F).
Q: Can I buy Bevyxxa online in India?
A: Yes. Bevyxxa 40 mg and 80 mg capsules can be legally imported via Global Rare Meds with a valid prescription.
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
